Dasatinib Effective Against Imatinib-Resistant Leukemia
NEW YORK (Reuters Health) May 01 - The kinase inhibitor dasatinib induces complete responses in patients with imatinib-resistant or imatinib-intolerant chronic myeloid leukemia (CML) in blast crisis, according to the results of a phase II study reported in the April 15th issue of Blood.
for full article copy and paste link below
http://www.medscape.com/viewarticle/555906?src=mp
Blood 2007;109:3207-3213.
Hi Sandy, this is a great result, but I am really concerned that we ( in England ) will have a battle to get it if required, having looked at previous posts and having just seen an article in the Daily Express.
The article ( and a previous post ) reported the fact that Dasatinib will be availabe in Scotland but not in England as NICE has not even been asked to look at it . This is,in my view, a disgrace, is there anything we can do as a group or as individuals to get this looked at ? Perhaps the reporter asking for CML'ers and pregnancy experiences might also mention that the people involved may also be denied treatment dependant on where they live.
Craig A
hi craig,
please read my comments about this on my post about SMC.
i believe we should all act now and fill in the NICE online topic suggestion form 'en masse' maybe they would notice!!!
sandy C ;o)
